Results of the logrank test and survival for each group.<\/em><\/em><\/em><\/em><\/em><\/em><\/p>\n\n\n\nVariable<\/td> Group<\/td> Survival prob.12 months<\/td> Survival median<\/td> Logrank test (\u03c72<\/sup>)<\/td> p<\/em>-value<\/td><\/tr> age<\/td> Less than 5
5 to 10
10 to 32
More than 32<\/td>54.9%
64.89%
43%
48.35%<\/td>15
22
10
11<\/td>204.78<\/td> <.01<\/td><\/tr> maccess<\/td> Less than 0.3
0.3 to 0.51
0.51 to 0.80
More than 0.80<\/td>40.56%
51.41%
59.80%
62.44<\/td>9
13
20
21<\/td>294.44<\/td> <.01<\/td><\/tr> nentries<\/td> Less than 6
6 to 17
17 to 40
More than 40<\/td>12.14%
28.53%
63.70%
91.86%<\/td>4
7
17
39<\/td>3721.13<\/td> <.01<\/td><\/tr> cfreq<\/td> 1
2
More than 2<\/td>53.77%
48.34%
62.83%<\/td>15
11
21<\/td>58.34<\/td> <.01<\/td><\/tr> nrenewals<\/td> 0
1
2
More than 2<\/td>1,90%
69.88%
85.49%
99.91%<\/td>5
16
27
inf<\/td>6264.73<\/td> <.01<\/td><\/tr> imonth<\/td> Quarter 1
Quarter 2
Quarter 3
Quarter 4<\/td>51.95%
47.06%
57.02%
51.28%<\/td>15
11
16
13<\/td>86.33<\/td> <.01<\/td><\/tr> gender<\/td> Male (1)
Female (0)<\/td>54.57%
51.47%<\/td>15
13<\/td>10.69<\/td> <.01<\/td><\/tr> Note. inf represents a value not possible to estimate. The enrolment months were grouped into quarter categories: Quarter 1 corresponds to month 1, 2 and 3: Quarter 2 months 4, 5 and 6; Quarter 3 months 7, 8 and 9 and Quarter 4 months 10, 11 and 12.
Source: own elaboration.<\/td><\/tr><\/tbody><\/table>\n\n\n\n